BigDNA relaunches as Iceni Pharmaceuticals with the aim to develop repurposed and reformulated cancer...
Up To Date
Latest News
One of the pioneering companies developing pharmaceuticals and diagnostics based on the gut microbiome,...
The long awaited global review on antimicrobial resistance by economist Lord Jim O’Neill has been published....
Bayer is deepening its involvement in CRISPR with a licensing agreement for genome editing patents. Irish...
Newly spun out company OxStem has raised £16.9m (€21.5m) to develop regenerative meds for the treatment of...
Swiss Genentech partner AC Immune has raised CHF42.7m (€38.6m) in order to advance its therapeutic and...
Share
